Characteristics of Mycoplasma hominis adhesion.
Mycoplasma hominis, a human pathogen, has previously been observed to bind to sulfatide separated on thin-layer chromatograms. It has not been demonstrated, however, that the binding is not simply a nonspecific ionic interaction. The ability of a low-passage patient isolate of M. hominis to adhere to glycoconjugates other than sulfatide and the characteristics of its binding to sulfatide were studied. Mycoplasmas were found to bind strongly and specifically in a temperature- and dose-dependent manner to only sulfatide of all of the glycolipids and glycoproteins tested. The avidity and specificity of binding, as well as the ability to inhibit the interaction specifically, suggest that the receptors to which M. hominis binds, particularly in the human urogenital tract, from which it is frequently isolated, are primarily, if not solely, sulfated glycolipids.
Center for Biologics Evaluation and Reserch, Food and Drug Administration, Rockville, Maryland 20852-1448.
L D
LD
Olson
A A
AA
Gilbert
D001422:Bacterial Adhesion; D016264:Dextran Sulfate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006017:Glycolipids / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D050356:Lipid Metabolism; D009174:Mycoplasma / Q000502:physiology*; D011134:Polysaccharides / Q000494:pharmacology; D013433:Sulfoglycosphingolipids / Q000378:metabolism*
D006017:Glycolipids; D006023:Glycoproteins; D011134:Polysaccharides; D013433:Sulfoglycosphingolipids; D016264:Dextran Sulfate; C007789:fucoidan